
Robert Calloway is The Trade Signal's specialist on pharmaceutical trade, covering the complex global supply chains that connect Indian drug manufacturers to markets worldwide. He tracks active pharmaceutical ingredient exports, formulation shipments, and the competitive dynamics between generic producers across jurisdictions. His coverage spans FDA regulatory pathways and the evolving landscape of pharma trade policy. Robert combines trade data analysis with regulatory expertise to provide insights into how policy decisions affect pharmaceutical supply chains.